| |
Protocol Number:
92-C-0094
- Title:
Continuing Treatment for Children and Adults in the Center for Cancer Research
- Number:
92-C-0094
- Summary:
This protocol is to provide continuing medical/surgical/radio-therapeutic care, treatment and follow-up for NCI patients not currently entered on an active research protocol. No investigational treatments will be administered on this protocol.
- Sponsoring Institute:
-
National Cancer Institute (NCI)
- Recruitment Detail
- Type:
Participants currently recruited/enrolled
- Gender:
Male & Female
- Referral Letter Required:
No
- Population Exclusion(s):
None
- Eligibility Criteria:
INCLUSION CRITERIA:
Subjects of any age who have been previously enrolled and treated on an approved CCR research treatment protocol.
It is in the best interests of the subject and the CCR for the subject to continue to receive treatment and follow-up at the NIH.
The subject or guardian signs the informed consent and agrees to the proposed treatment regimen.
EXCLUSION CRITERIA:
Subjects who have not been previously treated on a CCR research treatment protocol.
Subjects who are receiving an investigational therapy.
- Special Instructions:
Currently Not Provided
- Keywords:
-
Standard Care
-
Follow-Up
-
Bridge Protocol
- Recruitment Keyword(s):
-
None
- Condition(s):
-
Acquired Immunodeficiency Syndrome
-
Neoplasm
-
Skin Disease
-
HIV Infections
- Investigational Drug(s):
- None
- Investigational Device(s):
- None
- Intervention(s):
- None
- Supporting Site:
- National Cancer Institute
- Contact(s):
-
NCI Referral Office
National Institute of Health Clinical Center (CC), 9000 Rockville Pike, Bethesda, Maryland 20892, United States: NCI Clinical Trials Referral Office
Phone: 1-888-NCI-1937
Fax: Not Listed
Electronic Address: ncicssc@mail.nih.gov
- Citation(s):
Not Provided
If you have:
Search The Studies | Help | Questions |
Clinical Center Home | NIH Home
 National Institutes of Health Clinical Center
Bethesda, Maryland 20892. Last update: 05/05/2009
|
|
